TrialThe American journal of clinical nutrition2011

Soy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer risk.

Kenneth D R Setchell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.